Tech Company Financing Transactions
Surface Oncology Funding Round
On 1/9/2015, Surface Oncology landed $35 million in Series A investment from Atlas Venture, F-Prime Capital and Amgen Ventures.
Transaction Overview
Company Name
Announced On
1/9/2015
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Email Address
Not Recorded
Overview
Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno-biology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Grayzel
Chief Technical Officer
Scott Chappel
VP - Bus. Development
Nick Buffinger
Browse more venture capital transactions:
Prev: 1/9/2015: ViewRay venture capital transaction
Next: 1/9/2015: Source4Style venture capital transaction
Share this article
Where The Data Comes From
We record all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs